Literature DB >> 10773173

An NIMH perspective on the use of placebos. National Institute of Mental Health.

S E Hyman, D Shore.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10773173     DOI： 10.1016/s0006-3223(99)00292-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  3 in total

1.  Ethical issues in schizophrenia research: a commentary on some current concerns.

Authors:  David Shore
Journal:  Schizophr Bull       Date:  2005-11-30       Impact factor: 9.306

2.  Clinical trials of drugs used off-label in neonates: ethical issues and alternative study designs.

Authors:  Sanjiv B Amin; Michael P McDermott; Adil E Shamoo
Journal:  Account Res       Date:  2008 Jul-Sep       Impact factor: 2.622

3.  Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation.

Authors:  Laura Weiss Roberts; Teddy D Warner; Khanh P Nguyen; Cynthia M A Geppert; Melinda K Rogers; Brian B Roberts
Journal:  Psychopharmacology (Berl)       Date:  2003-05-17       Impact factor: 4.530
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.